# K151271: BellaFuse

- Pathway: 510(k) (Traditional)
- Applicant: Hans Biomed Corp.
- Decided: Mar 11, 2016 after 303 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K040980 (2004). 8 ancestors in all.
No later device cites it as a predicate yet.
0 of 9 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K043421: Opteform, Osteofil, Rti Allograft Paste IC, Rti Allograft Strip IC, Regeneration Technologies, Inc. (2005) Summary page 4.
- K062205: DBX Strip, Musculoskeletal Transplant Foundation (2007) Summary page 4.
- K113728: Surfuse Gel and Putty, Exfuse Gel and Putty, Hans Biomed Corp. (2012) Summary page 4.

## Indications for use
BellaFuse™ is an implant intended to fill bony voids or gaps of the skeletal system i.e., posterolateral spine. These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. BellaFuse™ resorbs and is replaced with bone during the healing process.

Source page: https://510kreport.com/device/K151271
Methodology: https://510kreport.com/methodology